SILVANA DE CASTRO FARIA to Dose-Response Relationship, Drug
This is a "connection" page, showing publications SILVANA DE CASTRO FARIA has written about Dose-Response Relationship, Drug.
Connection Strength
0.024
-
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes. J Clin Oncol. 2012 Nov 20; 30(33):4161-7.
Score: 0.015
-
A phase I surrogate endpoint study of SU6668 in patients with solid tumors. Invest New Drugs. 2004 Nov; 22(4):459-66.
Score: 0.009